The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.
ALK
NSCLC
targeted therapies
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Jun 2022
30 Jun 2022
Historique:
received:
12
05
2022
revised:
24
06
2022
accepted:
28
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
The severe prognosis linked with a lung cancer diagnosis has changed with the discovery of oncogenic molecularly driven subgroups and the use of tailored treatment. ALK-translocated advanced lung cancer is the most interesting model, having achieved the longest overall survival. Here, we report the most important paradigmatic shifts in the prognosis and treatment for this subgroup population occurred among lung cancer.
Identifiants
pubmed: 35806325
pii: ijms23137322
doi: 10.3390/ijms23137322
pmc: PMC9266866
pii:
doi:
Substances chimiques
EML4-ALK fusion protein, human
0
Oncogene Proteins, Fusion
0
Receptor Protein-Tyrosine Kinases
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Oncol. 2020 Nov 1;38(31):3592-3603
pubmed: 32780660
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Oncotarget. 2018 Feb 26;9(20):15340-15349
pubmed: 29632648
N Engl J Med. 2014 Dec 4;371(23):2167-77
pubmed: 25470694
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
Radiat Oncol. 2012 May 28;7:77
pubmed: 22640600
Lancet Oncol. 2018 Dec;19(12):1654-1667
pubmed: 30413378
J Thorac Oncol. 2017 Sep;12(9):1357-1367
pubmed: 28729021
Chest. 2005 Jul;128(1):452-62
pubmed: 16002972
J Thorac Oncol. 2019 Apr;14(4):683-690
pubmed: 30529198
N Engl J Med. 2020 Nov 19;383(21):2018-2029
pubmed: 33207094
J Thorac Oncol. 2020 Mar;15(3):404-415
pubmed: 31756496
Pharmaceuticals (Basel). 2020 Dec 18;13(12):
pubmed: 33352844
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Cancers (Basel). 2017 Sep 05;9(9):
pubmed: 28872581
Mol Cancer Ther. 2021 Sep;20(9):1499-1507
pubmed: 34158340
J Thorac Oncol. 2021 May;16(5):e31-e32
pubmed: 33896577
J Thorac Oncol. 2015 May;10(5):e26-e27
pubmed: 25898960
Clin Cancer Res. 2016 Nov 15;22(22):5527-5538
pubmed: 27780853
Semin Respir Crit Care Med. 2000;21(5):443-9
pubmed: 16088755
Cancer Discov. 2014 Jun;4(6):662-673
pubmed: 24675041
Ann Oncol. 2020 Aug;31(8):1056-1064
pubmed: 32418886
Int J Cancer. 2014 Mar 15;134(6):1484-94
pubmed: 24037730
Oncotarget. 2017 Mar 28;8(13):21903-21917
pubmed: 28423535
Cochrane Database Syst Rev. 2022 Jan 7;1:CD013453
pubmed: 34994987
J Neurosurg. 2002 Dec;97(5 Suppl):499-506
pubmed: 12507085
J Clin Oncol. 2013 Aug 10;31(23):2895-902
pubmed: 23835707
N Engl J Med. 2002 Jan 10;346(2):92-8
pubmed: 11784875
J Thorac Oncol. 2019 Apr;14(4):691-700
pubmed: 30599201
Lancet. 2016 Sep 3;388(10048):1012-24
pubmed: 27598681
Future Oncol. 2022 Jan;18(3):385-402
pubmed: 34783600
Lancet. 2013 Aug 24;382(9893):709-19
pubmed: 23972814
Cancer Discov. 2012 Jun;2(6):495-502
pubmed: 22614325
Clin Epidemiol. 2014 Nov 20;6:423-32
pubmed: 25429239
J Clin Oncol. 2018 Aug 1;36(22):2251-2258
pubmed: 29768118
Lancet. 2017 Mar 4;389(10072):917-929
pubmed: 28126333
J Thorac Oncol. 2020 Feb;15(2):258-265
pubmed: 31669591
J Clin Oncol. 2014 Jun 20;32(18):1874-81
pubmed: 24841982
J Clin Oncol. 2017 Apr 1;35(10):1070-1077
pubmed: 28113019
J Clin Oncol. 2015 Jun 10;33(17):1881-8
pubmed: 25624436
J Clin Oncol. 2011 May 20;29(15):e443-5
pubmed: 21422405
JAMA. 2014 May 21;311(19):1998-2006
pubmed: 24846037
J Clin Oncol. 2019 Jun 1;37(16):1370-1379
pubmed: 30892989
J Thorac Oncol. 2022 Apr;17(4):568-577
pubmed: 35026476
Lancet. 2017 Jul 1;390(10089):29-39
pubmed: 28501140
J Thorac Oncol. 2019 Sep;14(9):1547-1555
pubmed: 31108247
Sci Rep. 2020 Dec 3;10(1):21063
pubmed: 33273548
N Engl J Med. 2013 Jun 20;368(25):2385-94
pubmed: 23724913
Nature. 2007 Aug 2;448(7153):561-6
pubmed: 17625570
J Thorac Oncol. 2019 Jul;14(7):1233-1243
pubmed: 30902613
JAMA Oncol. 2021 Nov 01;7(11):1617-1625
pubmed: 34473194
Lancet Oncol. 2014 Feb;15(2):143-55
pubmed: 24411639
Cancer Discov. 2016 Oct;6(10):1118-1133
pubmed: 27432227
Clin Chest Med. 2020 Mar;41(1):67-85
pubmed: 32008630
Cancer Immunol Immunother. 2022 Feb;71(2):251-265
pubmed: 34125345
Thorac Surg Clin. 2020 May;30(2):137-146
pubmed: 32327172